Zimmer Biomet Holdings (ZBH) Raw Materials (2011 - 2026)

Zimmer Biomet Holdings' Raw Materials history runs 16 years deep, the most recent figure standing at $285.5 million for Q1 2026.

• On a quarterly basis, Raw Materials rose 4.85% year-over-year to $285.5 million in Q1 2026; TTM through Mar 2026 was $285.5 million, a 4.85% increase from a year earlier, with the FY2025 full-year figure at $273.2 million, down 5.3% from the prior year.
• Raw Materials rose to $285.5 million in Q1 2026 per ZBH's latest filing, from $273.2 million in the prior quarter.
• Across five years, Raw Materials topped out at $314.8 million in Q1 2024 and bottomed at $223.4 million in Q2 2022.
• The 5-year median for Raw Materials is $285.5 million (2026), against an average of $278.3 million.
• Across the five-year window, Raw Materials decreased 20.07% in 2022 and soared 31.83% in 2023, its largest moves.
• Year by year, Raw Materials stood at $261.3 million in 2022, then rose by 17.68% to $307.5 million in 2023, then slipped by 6.18% to $288.5 million in 2024, then decreased by 5.3% to $273.2 million in 2025, then increased by 4.5% to $285.5 million in 2026.
• Per Business Quant, the three latest ZBH Raw Materials figures stand at $285.5 million (Q1 2026), $273.2 million (Q4 2025), and $275.1 million (Q3 2025).